highperformr logo

4basebio's Overview

Total employees115
HeadquartersCambridge
Founded

4basebio PLC is a dynamic life sciences company focused on advancing next-generation therapies through innovative synthetic DNA and RNA solutions. They specialize in the development, manufacturing, and supply of high-purity, GMP-grade DNA (specifically opDNA™ and oeDNA™) and RNA products crucial for gene therapies, gene vaccines, cell therapies, and mRNA applications. With a commitment to quality and scalability, 4basebio supports biotech and pharmaceutical companies from research through to commercialization, enabling the development of novel treatments for a range of diseases. Their proprietary enzymatic synthesis technology offers advantages in terms of speed, quality, and complexity over traditional plasmid-based methods.

Where is 4basebio's Headquarters?

HQ Function

The Cambridge headquarters serves as the central hub for corporate operations, strategic leadership, research and development oversight, and business development for 4basebio's global activities.

Notable Features:

Located within a key UK biotech cluster, likely featuring modern laboratory and office spaces suited for advanced life sciences R&D and corporate functions.

Work Culture:

The work culture is expected to be collaborative, innovative, and science-driven, fostering a dynamic environment for researchers and professionals dedicated to advancing gene and cell therapies.

HQ Significance:

Its strategic location in one of Europe's leading biotechnology ecosystems facilitates innovation, access to talent, partnerships, and collaboration with research institutions.

Values Reflected in HQ: The headquarters likely reflects 4basebio's commitment to innovation, scientific excellence, quality, and collaboration, essential values for a company at the forefront of genetic medicine.

Location:

4basebio supports its global client base in the pharmaceutical and biotechnology sectors through its strategically located facilities in the UK (Cambridge), Germany (Heidelberg), and Spain (Granada). These sites enable research, development, manufacturing, and commercial supply of its advanced DNA and RNA products, serving markets across Europe, North America, and Asia-Pacific. Their global presence facilitates collaborations and ensures efficient delivery of solutions for gene therapies, vaccines, and diagnostics worldwide.

Street Address:

25 Norman Way, Over

City:

Cambridge

State/Province:

Cambridgeshire

Country:

United Kingdom

4basebio's Global Presence

Heidelberg, Baden-Württemberg, Germany

Address: Waldhofer Str. 102, 69123 Heidelberg, Germany

Serves as a crucial operational and R&D hub in continental Europe, supporting the development and production of advanced DNA technologies and enzymes for the European and global markets.

Granada, Andalusia, Spain

Address: Parque Tecnológico de la Salud, Avicena 8, planta 2, oficina B20, 18016 Granada, Spain

A key manufacturing and R&D site, particularly for its proprietary enzymatic DNA synthesis technologies, expanding 4basebio's production capabilities and scientific expertise in Southern Europe.

Buying Intent Signals for 4basebio

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of 4basebio

As of April 2025, 4basebio' leadership includes:

Dr. Heikki Lanckriet - Chief Executive Officer & Chief Scientific Officer
Claire Thomson - Chief Financial Officer & Company Secretary
Dr. Nick Monsour - Chief Business Development Officer
Gerry Brandon - Non-Executive Chairman
Dr. Anja Garritsen - Non-Executive Director
Dr. Lorenz Mayr - Non-Executive Director

Investors of 4basebio

4basebio has been backed by several prominent investors over the years, including:

Dr. Heikki Lanckriet
Lombard Odier Asset Management
Mr G A H H Weston
Interactive Investor
Hargreaves Lansdown (Nominees) Limited
Close Brothers Asset Management

Executive New Hires/Exits in the Last 12 Months

Hire1
Exits1

In the past 12 months, 4basebio has seen a key transition in its finance leadership, with the appointment of a new Chief Financial Officer, Claire Thomson, who replaced Marcus Karia.

Departures

Marcus Karia, Marcus Karia stepped down as CFO and Company Secretary to pursue another opportunity.

New Appointments:

Claire Thomson, Claire Thomson appointed as new Chief Financial Officer and Company Secretary.

Technology (Tech Stack) used by 4basebio

Discover the tools 4basebio uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

4basebio Email Formats and Examples

4basebio primarily uses the [first_name].[last_name]@4basebio.com email format for its employees. This is a common professional email structure.

[first_name].[last_name]@4basebio.com

Format

heikki.lanckriet@4basebio.com

Example

85%

Success rate

News and media

4basebio PLC / London Stock Exchange RNSApril 29, 2024

4basebio Announces Final Results for the Year Ended 31 December 2023

4basebio PLC reported its audited final results for 2023, highlighting progress in its DNA manufacturing capabilities, client acquisition, and strategic objectives. The company noted increased revenues (GBP £1.7 million) and continued investment in R&D and production scale-up for its synthetic DNA products....more

Proactive Investors / London Stock Exchange RNSFebruary 1, 2024

4basebio appoints new CFO Claire Thomson

4basebio PLC announced the appointment of Claire Thomson as chief financial officer and company secretary, effective immediately. Thomson brings over 20 years of experience in finance roles within the life sciences and technology sectors, succeeding Marcus Karia....more

Sharecast / Proactive InvestorsOctober 16, 2023

4basebio signs opDNA™ supply agreement with US biotech for novel cancer vaccine

4basebio PLC signed a supply agreement with a US-based biotechnology company for its synthetic DNA product, opDNA™, to be used in the development of a novel multi-neoantigen cancer vaccine. This marks a significant commercial milestone and validation for 4basebio's technology....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including 4basebio, are just a search away.